We have located links that may give you full text access.
Prognostic Significance of Mitotic Activity in Noninvasive, Low-Grade, Papillary Urothelial Carcinoma.
Analytical and Quantitative Cytopathology and Histopathology 2016 Februrary
OBJECTIVE: To identify the most useful method to detect the mitotic count (MC) by comparing different techniques, to determine a cutoff value for mitotic activity (MA), and to evaluate the correlation of this value with the recurrence of noninvasive low-grade papillary urothelial neoplasm (LGPUC).
STUDY DESIGN: Hematoxylin and eosin-stained slides of 55 LGPUC cases were evaluated for their MA. MC was determined using 4 different methods. In Method 1, cases with 3 mitoses in 1 single focus of a high-power field (HPF x 400) were found, and in Method 2, cases with ≥ 5 mitoses in 1 singlefocus of an HPF, in any level of the neoplastic epithelium, were determined. The areas with the highest MA values in the lower third and those with the highest MA values in the upper two-thirds of the neoplastic epithelium were marked in Methods 3 and 4, respectively. Then, mitotic figures were counted in these fields, and cases with 5 mitoses were determined.
RESULTS: In the recurrent group the number of cases with ≥ 5 mitoses, as detected by Methods 2 and 4, was significantly higher than that found for the nonrecurrent group (p = 0.0001 and p = 0.002, respectively). The number of mitoses, as detected by Methods 1 and 3, was not significantly different between the groups.
CONCLUSION: We suggest that determining MC may be used as a prognostic marker to predict LGPUC recurrence and that the mitotic numbers should be included in the initial pathology report to guide the clinician in patient management.
STUDY DESIGN: Hematoxylin and eosin-stained slides of 55 LGPUC cases were evaluated for their MA. MC was determined using 4 different methods. In Method 1, cases with 3 mitoses in 1 single focus of a high-power field (HPF x 400) were found, and in Method 2, cases with ≥ 5 mitoses in 1 singlefocus of an HPF, in any level of the neoplastic epithelium, were determined. The areas with the highest MA values in the lower third and those with the highest MA values in the upper two-thirds of the neoplastic epithelium were marked in Methods 3 and 4, respectively. Then, mitotic figures were counted in these fields, and cases with 5 mitoses were determined.
RESULTS: In the recurrent group the number of cases with ≥ 5 mitoses, as detected by Methods 2 and 4, was significantly higher than that found for the nonrecurrent group (p = 0.0001 and p = 0.002, respectively). The number of mitoses, as detected by Methods 1 and 3, was not significantly different between the groups.
CONCLUSION: We suggest that determining MC may be used as a prognostic marker to predict LGPUC recurrence and that the mitotic numbers should be included in the initial pathology report to guide the clinician in patient management.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app